According to the recommendations by the radioembolization brachytherapy oncology consortium (REBOC) (Kennedy et al. 2007), the team performing radioembolization should include individuals with sufficient expertise to:

While the interventional radiologist is particularly responsible for the assessment and delivery of the ^99mTc MAA angiography and radioembolization procedure, further care for the treated patients is usually assumed by the referring clinician or another designated member of the multidisciplinary team (Dezarn 2008).

Before SIRT, the technical complexity, the potential outcomes and complications of the diagnostic workup (^99mTc MAA angiography) and the radioembolization procedure should be extensively explained to each patient in a dedicated counselling interview.

Furthermore, during this first clinical appointment the suitability and physical fitness of the patient should be evaluated. Referral for SIRT should never imply an obligation to treat the patient. At least 24 h prior to both the diagnostic ^99mTc MAA angiography and the radioembolization procedure, patients’ written consent should be documented. After SIRT, each case should be reviewed again by the multidisciplinary team in order to inform the team members with respect to subsequent treatment decisions. Moreover, at discharge the patient should receive recommendations and information on further hydration and nutrition, peri-procedural medication, radiation safety instructions, the next necessary follow-up visits, and contact details in case of post-procedural side-effects.